Egyptian Drug Authority · Egypt
DEA-EG-2024-0004
Tier 1 · Regulator-publishedUnclassifiedPublic warningStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- periodic report no (4) For 2024
- Date issued
- Feb 2024
- Recorded by us
- 2026-09-06 19:45:29 UTC
- Product
- Ciprofar 500 mg
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Manufacturer
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Batch numbers
- Not published with the notice
- Expiry dates
- Not published with the notice
- Action type
- Public warning
- Classification
- Not stated by the issuing authority
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Not stated by the issuing authority
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Notice text
- Ciprofar 500mg
Pharco pharmaceuticals
1928
طبقا لإفادة الشركة حول وجود عبوات
مقلدةمن الصنف المذكور
وقف تداول و ضبط وتحريز المستحضر
المقلد
عدم شراء المستحضرات الصيدليةالا
من الصيدليات المرخصة.
في حالة الشك في المستحضر الصيدلى
يتم الرجوع الى هيئة الدواء المصرية
سواء بالإتصال بالخط الساخن 15301او
الموقع الإلكترونى الخاص بالهيئة.
يمكن الضغط على الرابطللإطلاععلى
الصور الخاصة بالمستحضر المقلد.
فبراير 2024
منشور
غش تجاري
اسم المستحضر
الشركة المنتجة
رقم التشغيلة
سبب التحذير
الإجراءات
التصحيحية
نصائح
للمستهلكينOriginal language: ar
- Notice text in English
- Notice. Counterfeit packs of Ciprofar 500mg, of Pharco Pharmaceuticals, batch 1928, have been reported by the company. Circulation of the counterfeit product is to stop and the product is to be impounded and seized. Pharmaceutical products should be bought only from licensed pharmacies. Anyone in doubt about a pharmaceutical product should contact the Egyptian Drug Authority, by its hotline 15301 or through its website.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- Status
- Active
- Superseded by
- Not superseded. This is the current version.
- Version
- 1
Where this record came from, and what is held to show it.
- Primary source
- https://edaegypt.gov.eg/media/tjbahtb5/%D9%85%D9%86%D8%B4%D9%88%D8%B1-4-%D9%84%D8%B3%D9%86%D8%A9-2024.pdf
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- 6dc5a5d040e6d31ca508ac63b61b941ca27f1df36da6ae00bae8074afb221376SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:39:46 UTC
Cite this record
Drug Eye Africa (2024). DEA-EG-2024-0004: Ciprofar 500 mg — Public warning, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2024/dea-eg-2024-0004Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.